Mark Alan Smith - CHIEF MEDICAL OFFICER at Vistagen Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Medical Officer
Stock Symbol
VTGN on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Mark Alan Smith since 4/23/2024

Holdings reported by Mark Alan Smith for Vistagen Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 19.9K $34.2K $1.72 Jun 30, 2022 Direct
Stock Option (Right to Buy) 150K Mar 1, 2022 Direct Common Stock

Transactions reported by Mark Alan Smith for Vistagen Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.